Presented by Lauren Held, PharmD, BCOP,(1) Sandra Kurtin,(2) PhD, ANP-C, AOCN®, and Lee Schwartzberg,(3) MD, FACP
From (1)Seattle Cancer Care Alliance, Seattle, Washington; (2)University of Arizona Cancer Center, Tucson, Arizona; (3)West Cancer Center, Memphis, Tennessee
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2020;11(3):234–238 |
© 2020 Harborside™
This JADPRO Live session tested attendees’ knowledge on biomarkers and their use in determining targeted therapy for certain tumor types, key assays used to measure common biomarkers, and guideline-endorsed biomarker testing recommendations.
For access to the full length article, please sign in